Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biodesy Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10542
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also develops and provides technology based on a phenomenon called second-harmonic generation that can monitor structural change within a protein in real time. Biodesy’s technology is used to measure functional activation in a protein, finds and validates compounds, and others. The company also provides compounds to treat Alzheimer’s and Parkinson’s diseases, cancers, cardiovascular diseases, and others. Biodesy is headquartered in San Francisco, California, the US.

Biodesy Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biodesy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biodesy Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Biodesy Raises USD20 Million in Series C Venture Financing 10
Biodesy Raises USD10 Million in Series B Financing 11
Biodesy Raises US$15 Million In Series A Financing 12
Partnerships 13
Biodesy Enters into Research Agreement with Amgen 13
Biodesy Inc – Key Competitors 14
Biodesy Inc – Key Employees 15
Biodesy Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jun 29, 2017: Biodesy Appoints Dominique Bridon as Chief Executive Officer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Biodesy Inc, Pharmaceuticals & Healthcare, Key Facts 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Biodesy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biodesy Raises USD20 Million in Series C Venture Financing 10
Biodesy Raises USD10 Million in Series B Financing 11
Biodesy Raises US$15 Million In Series A Financing 12
Biodesy Enters into Research Agreement with Amgen 13
Biodesy Inc, Key Competitors 14
Biodesy Inc, Key Employees 15

List of Figures
Biodesy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • London and Quadrant Housing Trust:企業の戦略・SWOT・財務情報
    London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report Summary London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bosideng International Holdings Limited:企業の戦略・SWOT・財務分析
    Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • API Group plc:企業の戦略・SWOT・財務情報
    API Group plc - Strategy, SWOT and Corporate Finance Report Summary API Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • University of Melbourne-医療機器分野:企業M&A・提携分析
    Summary The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medic …
  • BOE Technology Group Co Ltd:戦略・SWOT・企業財務分析
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務情報
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • AISIN SEIKI Co., Ltd.:企業の戦略・SWOT・財務分析
    AISIN SEIKI Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AISIN SEIKI Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Petrolympic Ltd (PCQ):企業の財務・戦略的SWOT分析
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • Lockheed Martin Corporation:戦略・SWOT・企業財務分析
    Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Horizon Healthcare Services Inc:企業の戦略的SWOT分析
    Horizon Healthcare Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Allianz Global Corporate & Specialty Singapore
    Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆